DK2766496T3 - Fremgangsmåder og processer for ikke-invasiv vurdering af genetiske variationer - Google Patents
Fremgangsmåder og processer for ikke-invasiv vurdering af genetiske variationer Download PDFInfo
- Publication number
- DK2766496T3 DK2766496T3 DK12778005.4T DK12778005T DK2766496T3 DK 2766496 T3 DK2766496 T3 DK 2766496T3 DK 12778005 T DK12778005 T DK 12778005T DK 2766496 T3 DK2766496 T3 DK 2766496T3
- Authority
- DK
- Denmark
- Prior art keywords
- chromosome
- nucleic acid
- counts
- sequence reads
- mapped
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Claims (14)
1. Fremgangsmåde til at bestemme fosterkøn, omfattende: (a) at opnå tællinger af nukleotidsekvenslæsninger kortlagt til et delområde af genomiske afsnit beliggende mellem basekoordinater 1 til 28.000.000 i et Y-kromosom af et referencegenom, hvilke sekvenslæsninger er læsninger af cirkulerende cellefri nukleinsyre fra en testprøve fra en gravid hun bærende på et foster; (b) at summere tællingerne kortlagt til delområdet af genomiske afsnit og sammenligne de summerede tællinger med en mediantælling for genomiske afsnit i Y-kromosomet for prøven, for derved at generere en sammenligning; og (c) at bestemme fosterkøn i henhold til sammenligningen.
2. System til at bestemme fosterkøn omfattende en eller flere processorer og hukommelse, hvilken hukommelse omfatter instruktioner der kan udføres af den ene eller flere processorer og hvilken hukommelse omfatter tællinger af nukleotidsekvenslæsninger kortlagt til et delområde af genomiske afsnit beliggende mellem basekoordinater 1 til 28.000.000 i et Y-kromosom af et referencegenom, hvilke sekvenslæsninger er læsninger af cirkulerende cellefri nukleinsyre fra en testprøve fra en gravid hun bærende på et foster; og hvilke instruktioner der kan udføres af den ene eller flere processorer er konfigureret til: (a) at summere tællingerne kortlagt til delområdet af genomiske afsnit og sammenligne de summerede tællinger med en mediantælling for genomiske afsnit i Y-kromosomet for prøven, for derved at generere en sammenligning; og (b) at bestemme fosterkøn i henhold til sammenligningen.
3. Fremgangsmåden ifølge krav 1 eller systemet ifølge krav 2, hvor delområdet af genomiske afsnit omfatter: a) genomiske afsnit med et konsistent antal af positive tællinger for kortlagte sekvenslæsninger fra prøver fra gravide hunner bærende hankønsfostre; b) genomiske afsnit med et konsistent antal af tællinger for kortlagte sekvenslæsninger fra prøver fra gravide hunner bærende hunkønsfostre; og c) genomiske afsnit med en signifikant og konsistent forskel af kortlagte sekvenslæsningstællinger mellem prøver fra gravide hunner bærende hankønsfostre og prøver fra gravide hunner bærende hunkønsfostre.
4. Fremgangsmåden ifølge krav 1 eller 3 eller systemet ifølge krav 2 eller 3, hvor delområdet af genomiske afsnit i Y-kromosomet ikke inkluderer udvalgte genomiske afsnit i Y-kromosomet, hvilke udvalgte genomiske afsnit i Y-kromosomet, når fjernet fra delområdet, resulterer i en forøgelse i et separationsmellemrum mellem hankøns- og hunkønsfostre større end eller lige med værdien ε = 1 %.
5. Fremgangsmåden ifølge krav 1, 3 eller 4 eller systemet ifølge et hvilket som helst af kravene 2 til 4, hvor antallet af sekvenslæsninger kortlagt til hver af de genomiske afsnit i delområdet er signifikant og konsistent højere for prøver fra gravide hunner bærende hankønsfostre versus prøver fra gravide hunner bærende hunkønsfostre.
6. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 5 eller systemet ifølge et hvilket som helst af kravene 2 til 5, hvor sekvenslæsningerne kortlagt til delområdet af genomiske afsnit er unikt kortlagte sekvenslæsninger.
7. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 6 eller systemet ifølge et hvilket som helst af kravene 2 til 6, hvor mediantællingen for genomiske afsnit i Y-kromosomet er lig med medianen af positiv værdi råsekvenslæsningstællinger i Y-kromosomet.
8. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 7 eller systemet ifølge et hvilket som helst af kravene 2 til 7, omfattende at bestemme en hankøn separatorområdescore (MSRscore) for antallet af nukleotidsekvenslæsninger kortlagt til hver af de genomiske afsnit i delområdet i henhold til Ligning A:
Li g n i ng A hvor S er en prøve, MSR er hankøn separatorområde, RAW er råsekvenslæsningstællinger, bm er et genomisk afsnit i MSR, og M er mediansekvenslæsningstælling.
9. Fremgangsmåden eller systemet ifølge krav 8, hvor mediansekvenslæsningstællingen (M) er en median af positiv værdi råsekvenslæsningstællinger for genomiske afsnit af Y-kromosom.
10. Fremgangsmåden eller systemet ifølge krav 8 eller 9, hvor fosterkønnet bestemmes som hankøn, når MSRscoren er 6,5 eller mere eller fosterkønnet bestemmes som hunkøn, når MSRscoren er mindre end 6,5.
11. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 10 eller systemet ifølge et hvilket som helst af kravene 2 til 10, hvor sammenligningen korreleres til fosterkvantifikationsresultater.
12. Fremgangsmåden eller systemet ifølge krav 11, hvor fosterkvantifikationsresultaterne er SRY-baserede kvantifikationsresultater.
13. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 12 eller systemet ifølge et hvilket som helst af kravene 2 til 12, hvor fosterkønnet bestemmes med en nøjagtighed på omkring 0,9938 eller større med et 95 % konfidensinterval, og fortrinsvis med en nøjagtighed på omkring 0,994 eller større med et 95 % konfidensinterval.
14. Fremgangsmåden ifølge et hvilket som helst af kravene 1 og 3 til 13 eller systemet ifølge et hvilket som helst af kravene 2 til 13, hvor prøven er blod, serum eller plasma.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161545977P | 2011-10-11 | 2011-10-11 | |
US201261663477P | 2012-06-22 | 2012-06-22 | |
US201261663361P | 2012-06-22 | 2012-06-22 | |
PCT/US2012/059592 WO2013055817A1 (en) | 2011-10-11 | 2012-10-10 | Methods and processes for non-invasive assessment of genetic variations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2766496T3 true DK2766496T3 (da) | 2017-05-15 |
Family
ID=48082404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12778005.4T DK2766496T3 (da) | 2011-10-11 | 2012-10-10 | Fremgangsmåder og processer for ikke-invasiv vurdering af genetiske variationer |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP3243908B1 (da) |
CA (1) | CA2851537C (da) |
DK (1) | DK2766496T3 (da) |
ES (1) | ES2624686T3 (da) |
HK (2) | HK1200875A1 (da) |
WO (1) | WO2013055817A1 (da) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
EP3660165B1 (en) | 2009-12-22 | 2023-01-04 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US20140235474A1 (en) | 2011-06-24 | 2014-08-21 | Sequenom, Inc. | Methods and processes for non invasive assessment of a genetic variation |
CA2850785C (en) | 2011-10-06 | 2022-12-13 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10196681B2 (en) | 2011-10-06 | 2019-02-05 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
ES2929923T3 (es) | 2012-01-20 | 2022-12-02 | Sequenom Inc | Procesos de diagnóstico que condicionan las condiciones experimentales |
EP2820129A1 (en) | 2012-03-02 | 2015-01-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
WO2013177086A1 (en) * | 2012-05-21 | 2013-11-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10504613B2 (en) | 2012-12-20 | 2019-12-10 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10497461B2 (en) * | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20140093873A1 (en) | 2012-07-13 | 2014-04-03 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US10482994B2 (en) | 2012-10-04 | 2019-11-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US10844424B2 (en) | 2013-02-20 | 2020-11-24 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
EP2959015B1 (en) | 2013-02-20 | 2020-11-04 | Bionano Genomics, Inc. | Characterization of molecules in nanofluidics |
EP2971100A1 (en) | 2013-03-13 | 2016-01-20 | Sequenom, Inc. | Primers for dna methylation analysis |
PL2981921T3 (pl) | 2013-04-03 | 2023-05-08 | Sequenom, Inc. | Metody i procesy nieinwazyjnej oceny zmienności genetycznych |
EP3004383B1 (en) | 2013-05-24 | 2019-04-24 | Sequenom, Inc. | Methods for non-invasive assessment of genetic variations using area-under-curve (auc) analysis |
AU2014284180B2 (en) | 2013-06-21 | 2020-03-19 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
WO2015051163A2 (en) * | 2013-10-04 | 2015-04-09 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CA2925111C (en) | 2013-10-07 | 2024-01-16 | Sequenom, Inc. | Methods and processes for non-invasive assessment of chromosome alterations |
CN106164295B (zh) | 2014-02-25 | 2020-08-11 | 生物纳米基因公司 | 减小基因组覆盖测量中的偏差 |
EP3736344A1 (en) | 2014-03-13 | 2020-11-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US11783911B2 (en) | 2014-07-30 | 2023-10-10 | Sequenom, Inc | Methods and processes for non-invasive assessment of genetic variations |
US20160085910A1 (en) * | 2014-09-18 | 2016-03-24 | Illumina, Inc. | Methods and systems for analyzing nucleic acid sequencing data |
JP6971845B2 (ja) | 2014-10-10 | 2021-11-24 | セクエノム, インコーポレイテッド | 遺伝子の変動の非侵襲的評価のための方法および処理 |
US9859394B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US9857328B2 (en) | 2014-12-18 | 2018-01-02 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same |
US10020300B2 (en) | 2014-12-18 | 2018-07-10 | Agilome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
WO2016100049A1 (en) | 2014-12-18 | 2016-06-23 | Edico Genome Corporation | Chemically-sensitive field effect transistor |
US10006910B2 (en) | 2014-12-18 | 2018-06-26 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
EP3378002A1 (en) * | 2015-11-16 | 2018-09-26 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN105925612A (zh) * | 2016-05-10 | 2016-09-07 | 华南农业大学 | 一种基于抑制Dby基因表达来进行小鼠性别控制的方法 |
EP3459115A4 (en) | 2016-05-16 | 2020-04-08 | Agilome, Inc. | GRAPHEN-FET DEVICES, SYSTEMS AND METHODS FOR USE THEREOF FOR SEQUENCING NUCLEIC ACIDS |
US20170342477A1 (en) | 2016-05-27 | 2017-11-30 | Sequenom, Inc. | Methods for Detecting Genetic Variations |
EP3491561A1 (en) | 2016-07-27 | 2019-06-05 | Sequenom, Inc. | Methods for non-invasive assessment of genomic instability |
WO2018022890A1 (en) | 2016-07-27 | 2018-02-01 | Sequenom, Inc. | Genetic copy number alteration classifications |
WO2018136881A1 (en) | 2017-01-20 | 2018-07-26 | Sequenom, Inc. | Sequencing adapter manufacture and use |
WO2018136882A1 (en) | 2017-01-20 | 2018-07-26 | Sequenom, Inc. | Methods for non-invasive assessment of copy number alterations |
CA3198931A1 (en) | 2017-01-20 | 2018-07-26 | Sequenom, Inc. | Methods for non-invasive assessment of genetic alterations |
JP7237003B2 (ja) | 2017-01-24 | 2023-03-10 | セクエノム, インコーポレイテッド | 遺伝子片の評価のための方法およびプロセス |
PT3596233T (pt) | 2017-03-17 | 2022-08-22 | Sequenom Inc | Métodos e processos para avaliação de mosaicismo genético |
JP2022553829A (ja) | 2019-10-31 | 2022-12-26 | セクエノム, インコーポレイテッド | 多胎児妊娠およびパーソナライズされたリスク評価におけるモザイク現象比の適用 |
CN110749733B (zh) * | 2019-12-06 | 2021-08-27 | 四川大学华西医院 | Tgif2ly自身抗体检测试剂在制备肺癌筛查试剂盒中的用途 |
CN112729460B (zh) * | 2020-12-28 | 2024-03-19 | 宁波铭瑞中兴电子科技有限公司 | 应用ups电源的液量检测方法、系统、智能终端及存储介质 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
CA2497988C (en) | 2002-09-06 | 2011-03-29 | The Trustees Of Boston University | Quantification of gene expression |
CA2507189C (en) | 2002-11-27 | 2018-06-12 | Sequenom, Inc. | Fragmentation-based methods and systems for sequence variation detection and discovery |
EP1641809B2 (en) | 2003-07-05 | 2018-10-03 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
CA2589487C (en) | 2004-11-29 | 2014-07-29 | Klinikum Der Universitat Regensburg | Means and methods for detecting methylated dna |
US8679741B2 (en) | 2006-05-31 | 2014-03-25 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
WO2007147063A2 (en) | 2006-06-16 | 2007-12-21 | Sequenom, Inc. | Methods and compositions for the amplification, detection and quantification of nucleic acid from a sample |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US20090029377A1 (en) | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
WO2009032779A2 (en) | 2007-08-29 | 2009-03-12 | Sequenom, Inc. | Methods and compositions for the size-specific seperation of nucleic acid from a sample |
ATE549419T1 (de) | 2007-08-29 | 2012-03-15 | Sequenom Inc | Verfahren und zusammensetzungen für die universelle grössenspezifische polymerasekettenreaktion |
AU2008308457A1 (en) | 2007-10-04 | 2009-04-09 | Halcyon Molecular | Sequencing nucleic acid polymers with electron microscopy |
AU2009228312B2 (en) | 2008-03-26 | 2015-05-21 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
CN103695530B (zh) | 2008-07-07 | 2016-05-25 | 牛津纳米孔技术有限公司 | 酶-孔构建体 |
EP3103871B1 (en) | 2008-09-16 | 2020-07-29 | Sequenom, Inc. | Processes for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for fetal nucleic acid quantification |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
WO2010065470A2 (en) * | 2008-12-01 | 2010-06-10 | Consumer Genetics, Inc. | Compositions and methods for detecting background male dna during fetal sex determination |
EP3211095B1 (en) | 2009-04-03 | 2019-01-02 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
ES2534758T3 (es) | 2010-01-19 | 2015-04-28 | Verinata Health, Inc. | Métodos de secuenciación en diagnósticos prenatales |
CA2786565C (en) * | 2010-01-19 | 2017-04-25 | Verinata Health, Inc. | Partition defined detection methods |
US20140227691A1 (en) | 2010-05-14 | 2014-08-14 | Fluidigm, Inc. | Nucleic acid isolation methods |
WO2012118745A1 (en) * | 2011-02-28 | 2012-09-07 | Arnold Oliphant | Assay systems for detection of aneuploidy and sex determination |
-
2012
- 2012-10-10 EP EP17159726.3A patent/EP3243908B1/en active Active
- 2012-10-10 DK DK12778005.4T patent/DK2766496T3/da active
- 2012-10-10 EP EP12778005.4A patent/EP2766496B1/en active Active
- 2012-10-10 CA CA2851537A patent/CA2851537C/en active Active
- 2012-10-10 WO PCT/US2012/059592 patent/WO2013055817A1/en active Application Filing
- 2012-10-10 ES ES12778005.4T patent/ES2624686T3/es active Active
-
2015
- 2015-02-04 HK HK15101187.4A patent/HK1200875A1/xx unknown
-
2018
- 2018-05-03 HK HK18105709.1A patent/HK1246362B/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1246362B (zh) | 2019-12-06 |
EP3243908A1 (en) | 2017-11-15 |
WO2013055817A1 (en) | 2013-04-18 |
EP3243908B1 (en) | 2019-01-02 |
HK1200875A1 (en) | 2015-08-14 |
CA2851537C (en) | 2020-12-29 |
EP2766496B1 (en) | 2017-03-08 |
ES2624686T3 (es) | 2017-07-17 |
CA2851537A1 (en) | 2013-04-18 |
EP2766496A1 (en) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020277215B2 (en) | Methods and processes for non-invasive assessment of genetic variations | |
US20210238669A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
DK2766496T3 (da) | Fremgangsmåder og processer for ikke-invasiv vurdering af genetiske variationer | |
US8688388B2 (en) | Methods and processes for non-invasive assessment of genetic variations | |
US20200105372A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
US20200075126A1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
EP2764459B1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
EP2981921B1 (en) | Methods and processes for non-invasive assessment of genetic variations |